Call Us for Free Consultation
May 11, 2010

Bayer admits thromboembolism effects and vascular problems with yasmin to fda

Yasmin supplemental new drug application provides for new information of  thromboembolism and vascular problems.

Bayer FDA Letter

Mr. Osborne is a seasoned trial lawyer with more than thirty years of litigation experience representing those injured in car accidents, by medical malpractice, or other forms of negligence. He is a member of the Nevada Justice Association and the Multi-Million Dollar Forum.

Related Posts